Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Egypt Inflation Drops: ETFs In Focus By Zacks Investment Research - Dec 12, 2017

Per the Central Bank of Egypt (CBE), on a year-over-year basis, Egypt’s core inflation dropped to 25.53% in November compared with 30.53% in October. Core inflation excludes volatile items such...

Zacks Investment Research
Bristol-Myers (BMY) Reports Positive Data On Leukemia Drug By Zacks Investment Research - Dec 12, 2017

Bristol-Myers Squibb Company (NYSE:BMY) announced positive data from phase II study, CA180-372, on Sprycel.Patients received Sprycel 60 mg/m2tablets or powder for oral suspension, once daily, in...

Zacks Investment Research
CVS-Aetna Deal Leading A Wave Of Change In Hospital Sector By Zacks Investment Research - Dec 12, 2017

The mega merger of CVS Health Corp. (NYSE:CVS) with Aetna Inc. (NYSE:AET) announced recently has sent jitters across the hospital sector, which is already suffering from low patient volumes,...

Zacks Investment Research
El Pollo Loco Expands Further In Arizona With New Outlet By Zacks Investment Research - Dec 12, 2017

El Pollo Loco Holdings, Inc. (NASDAQ:LOCO) recently opened its latest outlet in Avondale, AZ. The 2,995-square-foot restaurant that can accommodate 70 guests is the company’s first restaurant...

Zacks Investment Research
Regeneron's SBLA For Eylea Accepted By FDA, Action Date Set By Zacks Investment Research - Dec 12, 2017

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the FDA has accepted for review the company's supplemental Biologics License Application (sBLA) for the label expansion of Eylea...

Zacks Investment Research
Novartis Announces Positive Data On Sickle Cell Disease Drug By Zacks Investment Research - Dec 12, 2017

Novartis AG (NYSE:NVS) announced positive results from a post hoc subgroup analysis of the phase II study, SUSTAIN on pipeline candidate, crizanlizumab.The multicenter, multinational, randomized,...

Zacks Investment Research
ExxonMobil (XOM) Finds Crude Offshore Equatorial Guinea By Zacks Investment Research - Dec 12, 2017

The energy ministry of Equatorial Guinea announced findings of crude by ExxonMobil (NYSE:XOM) in the offshore EG-06 block. The largest publicly-traded energy company is presently evaluating the...

Zacks Investment Research
Wal-Mart Makes Online Holiday Buying Easy: What About Others? By Zacks Investment Research - Dec 12, 2017

If you haven’t completed your holiday shopping yet, Wal-Mart Stores Inc. (NYSE:WMT) surely has some good news for you. This supermarket giant, which is leaving no stone unturned to evolve with...

Zacks Investment Research
Whiting Petroleum (WLL) Expects Huge Impairment Charge In Q4 By Zacks Investment Research - Dec 12, 2017

Energy major Whiting Petroleum Corporation (NYSE:WLL) expects to incur an impairment charge of $800-$900 million in the fourth quarter of 2017. The charges are connected to the partial write-down of...

Zacks Investment Research
Will AT&T Be Back On Growth Path Despite Saturation In 2018? By Zacks Investment Research - Dec 12, 2017

It is turning out to be disappointing 2017 for AT&T Inc. (NYSE:T) . The U.S. telecom behemoth continues to struggle in the competitive and almost-saturated wireless market. Adoption of several...

Zacks Investment Research
Should You Buy Tencent (TCEHY) Stock Before 2018? By Zacks Investment Research - Dec 12, 2017

The tech industry helped lift markets and indexes in 2017, but as we near the start of 2018, some investors might begin to turn their attention to new industries. Nevertheless, dumping tech stocks...

Continue with Apple
Continue with Google
or
Sign up with Email